Who is sponsoring NCT05394961?

NCT05394961 is sponsored by Uppsala University.

What condition does NCT05394961 study?

NCT05394961 studies Sepsis, ARDS, Human, COVID-19.

What drugs are being tested in NCT05394961?

Interventions: Treatment in an intensive care unit with a diagnosis of sepsis and/or ARDS and/or covid-19.

What is the status of NCT05394961?

NCT05394961 is currently COMPLETED.

Last reviewed 2022-05-27 · How we verify

Factors Associated With Decisions to Withhold or Withdraw Intensive Care

NCT05394961 COMPLETED

Medical and socioeconomic data are extracted from the Swedish Intensive Care Registry (SIR), the Swedish National Patient Registry and Statistics Sweden for all adult patients admitted to in Swedish intensive care units between 2014-01-01 and 2020-12-31 with a diagnosis of sepsis and/or acute respiratory distress syndrome (ARDS) and/or coronavirus 19 (COVID-19) infection, and registered in SIR. The impact of demographic and socioeconomic factors on decisions to withhold or withdraw intensive care, and on mortality, are studied and statistically adjusted for level of chronic comorbidity and severity of acute illness.

Details

Lead sponsor	Uppsala University
Status	COMPLETED
Enrolment	33256
Start date	Thu Aug 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Aug 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Sepsis
ARDS, Human
COVID-19

Interventions

Treatment in an intensive care unit with a diagnosis of sepsis and/or ARDS and/or covid-19

Countries

Sweden